Elements of Th1/Th2 response and disease severity in COVID-19 patients : A short report

© 2021 Wiley Periodicals LLC..

The presence of a complex immune dysregulation syndrome has been established in COVID-19 patients. We aimed to assess Th1/Th2 response in COVID-19 patients and its association with disease severity by performing a prospective cohort study in a tertiary hospital COVID-19 referral center. We report no difference between Th1/Th2 responses between patients with severe and mild disease, except for levels of interleukin-6 (IL-6) and IL-10. Future larger studies should examine lung-specific versus systemic inflammatory responses, as well as, diverse immunotypes driving poor clinical outcomes.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:94

Enthalten in:

Journal of medical virology - 94(2022), 1 vom: 01. Jan., Seite 404-406

Sprache:

Englisch

Beteiligte Personen:

Akinosoglou, Karolina [VerfasserIn]
Delastic, Anne-Lise [VerfasserIn]
Dimakopoulou, Vasilina [VerfasserIn]
Marangos, Markos [VerfasserIn]
Gogos, Charalambos [VerfasserIn]

Links:

Volltext

Themen:

130068-27-8
COVID-19
IL10 protein, human
IL6 protein, human
Inflammation
Interleukin-10
Interleukin-6
Journal Article
SARS-CoV-2
Th1/Th2 response

Anmerkungen:

Date Completed 23.11.2021

Date Revised 11.12.2021

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1002/jmv.27313

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM330029207